PharmTech LCGC Sciex Webinar 11.10
|Articles|June 11, 2010

Agilent J&W Ultra Inert GC columns

Agilent J&W Ultra Inert GC columns push industry standards for consistent column inertness and exceptionally low column bleed, resulting in lower detection limits and more accurate data for difficult analytes.

Perform trace-level analysis with the utmost confidence

Agilent J&W Ultra Inert GC columns push the industry standards for consistent column inertness and exceptionally low column bleed, resulting in lower detection limits and more accurate data for difficult analytes. These columns are tested with the most demanding Ultra Inert test probe mixture in the industry, and a performance summary sheet is shipped with each column. So you can put 40 years of Agilent quality and innovation behind your every separation.

View Detailed Competitive Comparisons

When you download your copy of the Agilent J&W Ultra Inert and GC/MS Column Portfolio Brochure you will see this innovation and quality in action. In this full-color, 28-page brochure you will find side-by-side competitive comparisons along with detailed chromatograms showing the differences in peak shapes between different GC column vendors. You will see for yourself the sharp, symmetrical peaks and minimal temperature-dependent baseline drift achieved with Agilent J&W columns. This demonstration of real-world separations shows how Agilent J&W Ultra Inert GC columns put even “impossible” analyses well within your reach.

Download your copy of the Agilent J&W Ultra Inert and GC/MS Column Portfolio Brochure now.


Related to this article

Best of the Week: From Cancer Diagnostics to Smarter LC Method Development
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.